Nanogen, Inc. Extends Celera Corporation License Agreement for Additional IVD Products
SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of molecular-biology and rapid diagnostic products, announced today that Celera Corporation has extended its license agreement of Nanogen’s patent portfolio in molecular biology to develop additional diagnostic products.